GeoPolitics Pulse

The Heartbeat of World events

Leqembi’s UK Rollercoaster: A Yes From MHRA, A No From NICE – Pink Sheet

by ·

While the drug regulator has approved Eisai/Biogen’s early Alzheimer’s disease treatment, the health technology assessment institute is worried …Read More

Related posts:

  1. UK MHRA To Retain Multiple Approval Pathways From 2025 – Pink Sheet – Citeline
  2. Pink ODI South Africa: What is SA’s record in pink ODIs? | Sporting News India
  3. NICE Ltd. (NICE): Expanding AI-Driven Solutions with Strong Financial Results Google Alert – Artificial General Intelligence
  4. Working With The Inspectors: UK’s eXmoor Gets License To Make ATMPs – Pink Sheet
  5. Pharma Firms To Benefit From New UK Hub-And-Spoke Clinical Trial Network – Pink Sheet